51
|
Brognaux A, Han S, Sørensen SJ, Lebeau F, Thonart P, Delvigne F. A low-cost, multiplexable, automated flow cytometry procedure for the characterization of microbial stress dynamics in bioreactors. Microb Cell Fact 2013; 12:100. [PMID: 24176169 PMCID: PMC4228430 DOI: 10.1186/1475-2859-12-100] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2013] [Accepted: 10/30/2013] [Indexed: 12/20/2022] Open
Abstract
Background Microbial cell population heterogeneity is now recognized as a major source of issues in the development and optimization of bioprocesses. Even if single cell technologies are available for the study of microbial population heterogeneity, only a few of these methods are available in order to study the dynamics of segregation directly in bioreactors. In this context, specific interfaces have been developed in order to connect a flow cytometer directly to a bioreactor for automated analyses. In this work, we propose a simplified version of such an interface and demonstrate its usefulness for multiplexed experiments. Results A low-cost automated flow cytometer has been used in order to monitor the synthesis of a destabilized Green Fluorescent Protein (GFP) under the regulation of the fis promoter and propidium iodide (PI) uptake. The results obtained showed that the dynamics of GFP synthesis are complex and can be attributed to a complex set of biological parameters, i.e. on the one hand the release of protein into the extracellular medium and its uptake modifying the activity of the fis promoter, and on the other hand the stability of the GFP molecule itself, which can be attributed to the protease content and energy status of the cells. In this respect, multiplexed experiments have shown a correlation between heat shock and ATP content and the stability of the reporter molecule. Conclusion This work demonstrates that a simplified version of on-line FC can be used at the process level or in a multiplexed version to investigate the dynamics of complex physiological mechanisms. In this respect, the determination of new on-line parameters derived from automated FC is of primary importance in order to fully integrate the power of FC in dedicated feedback control loops.
Collapse
Affiliation(s)
| | | | | | | | | | - Frank Delvigne
- Unité de Bio-industries/CWBI, Gembloux Agro-Bio Tech, Université de Liège, Passage des Déportés 2, Gembloux 5030, Belgium.
| |
Collapse
|
53
|
Yang S, Kuang Y, Li H, Liu Y, Hui X, Li P, Jiang Z, Zhou Y, Wang Y, Xu A, Li S, Liu P, Wu D. Enhanced production of recombinant secretory proteins in Pichia pastoris by optimizing Kex2 P1' site. PLoS One 2013; 8:e75347. [PMID: 24069404 PMCID: PMC3777899 DOI: 10.1371/journal.pone.0075347] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2013] [Accepted: 08/12/2013] [Indexed: 12/12/2022] Open
Abstract
Pichiapastoris is one of the most widely used expression systems for the production of recombinant secretory proteins. Its universal application is, however, somewhat hampered by its unpredictable yields for different heterologous proteins, which is now believed to be caused in part by their varied efficiencies to traffic through the host secretion machinery. The yeast endoprotease Kex2 removes the signal peptides from pre-proteins and releases the mature form of secreted proteins, thus, plays a pivotal role in the yeast secretory pathways. In this study, we found that the yields of many recombinant proteins were greatly influenced by Kex2 P1' site residues and the optimized P1's amino acid residue could largely determine the final amount of secretory proteins synthesized and secreted. A further improvement of secretory yield was achieved by genomic integration of additional Kex2 copies, which again highlighted the importance of Kex2 cleavage to the production of recombinant secretory proteins in Pichia yeast.
Collapse
Affiliation(s)
- Song Yang
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
| | - Ye Kuang
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
- Department of Biomedical Engineering, School of Pharmaceutical Sciences, Jilin University, Changchun, China
| | - Hongbo Li
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
- The Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province, Department of Life Sciences, Huaihua College, Huaihua, China
| | - Yuehong Liu
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
- Department of Biomedical Engineering, School of Pharmaceutical Sciences, Jilin University, Changchun, China
| | - Xiaoyan Hui
- Department of Medicine, The University of Hong Kong, Hong Kong, China
| | - Peng Li
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
| | - Zhiwu Jiang
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
| | - Yulai Zhou
- Department of Biomedical Engineering, School of Pharmaceutical Sciences, Jilin University, Changchun, China
| | - Yu Wang
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
- Department of Medicine, The University of Hong Kong, Hong Kong, China
| | - Aimin Xu
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
- Department of Medicine, The University of Hong Kong, Hong Kong, China
| | - Shiwu Li
- Department of Pathology, University of Florida, Gainesville, Florida, United States of America
| | - Pentao Liu
- The Wellcome Trust Sanger Institute, Cambridge, United Kingdom
| | - Donghai Wu
- The Key Laboratory of Regenerative Biology and The Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
- * E-mail:
| |
Collapse
|
55
|
Love KR, Bagh S, Choi J, Love JC. Microtools for single-cell analysis in biopharmaceutical development and manufacturing. Trends Biotechnol 2013; 31:280-6. [DOI: 10.1016/j.tibtech.2013.03.001] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2012] [Revised: 03/01/2013] [Accepted: 03/02/2013] [Indexed: 01/10/2023]
|
56
|
Gasser B, Prielhofer R, Marx H, Maurer M, Nocon J, Steiger M, Puxbaum V, Sauer M, Mattanovich D. Pichia pastoris: protein production host and model organism for biomedical research. Future Microbiol 2013; 8:191-208. [DOI: 10.2217/fmb.12.133] [Citation(s) in RCA: 168] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Pichia pastoris is the most frequently used yeast system for heterologous protein production today. The last few years have seen several products based on this platform reach approval as biopharmaceutical drugs. Successful glycoengineering to humanize N-glycans is further fuelling this development. However, detailed understanding of the yeast’s physiology, genetics and regulation has only developed rapidly in the last few years since published genome sequences have become available. An expanding toolbox of genetic elements and strains for the improvement of protein production is being generated, including promoters, gene copy-number enhancement, gene knockout and high-throughput methods. Protein folding and secretion have been identified as significant bottlenecks in yeast expression systems, pinpointing a major target for strain optimization. At the same time, it has become obvious that P. pastoris, as an evolutionarily more ‘ancient’ yeast, may in some cases be a better model for human cell biology and disease than Saccharomyces cerevisiae.
Collapse
Affiliation(s)
- Brigitte Gasser
- University of Natural Resources & Life Sciences (BOKU), Department of Biotechnology, 1190 Vienna, Austria
- Austrian Centre of Industrial Biotechnology (ACIB GmbH), 1190 Vienna, Austria
| | - Roland Prielhofer
- University of Natural Resources & Life Sciences (BOKU), Department of Biotechnology, 1190 Vienna, Austria
| | - Hans Marx
- University of Natural Resources & Life Sciences (BOKU), Department of Biotechnology, 1190 Vienna, Austria
| | - Michael Maurer
- Austrian Centre of Industrial Biotechnology (ACIB GmbH), 1190 Vienna, Austria
- University of Applied Sciences FH-Campus Vienna, School of Bioengineering, 1190 Vienna, Austria
| | - Justyna Nocon
- University of Natural Resources & Life Sciences (BOKU), Department of Biotechnology, 1190 Vienna, Austria
| | - Matthias Steiger
- University of Natural Resources & Life Sciences (BOKU), Department of Biotechnology, 1190 Vienna, Austria
- Austrian Centre of Industrial Biotechnology (ACIB GmbH), 1190 Vienna, Austria
| | - Verena Puxbaum
- University of Natural Resources & Life Sciences (BOKU), Department of Biotechnology, 1190 Vienna, Austria
- Austrian Centre of Industrial Biotechnology (ACIB GmbH), 1190 Vienna, Austria
| | - Michael Sauer
- University of Natural Resources & Life Sciences (BOKU), Department of Biotechnology, 1190 Vienna, Austria
- Austrian Centre of Industrial Biotechnology (ACIB GmbH), 1190 Vienna, Austria
| | - Diethard Mattanovich
- University of Natural Resources & Life Sciences (BOKU), Department of Biotechnology, 1190 Vienna, Austria
| |
Collapse
|